Introduction .
Purpose .
The primary endpoint is overall survival ,  secondaryendpoints are disease-free survival ,  rate of loco-regionalrecurrence ,  and treatment-related toxicity/morbidity .
Materials and methods .
Dosage schedule .
Statistical and ethical considerations .
